Literature DB >> 12577233

Chemotherapy in biliary tract carcinomas: results in India.

Dinesh C Doval1, Jagdev S Sekhon, Sunil K Gupta, Sanjay Gupta, Bhawana S Awasthy.   

Abstract

Epidemiology data from India suggest that biliary tract carcinomas occur primarily in the older population. Because of the absence of early symptoms, most patients present with advanced disease, and the outcome has been disappointing even in patients with resectable tumors who have undergone aggressive surgery. Although there is no standard therapy, data from recent clinical trials warrant further investigation of the role of chemotherapy in biliary tract carcinoma. In view of the favorable toxicity profile and observed efficacy of gemcitabine in advanced biliary tract cancers, its evaluation in combination with other active, potentially synergistic cytotoxic drugs such as cisplatin, capecitabine, and carboplatin should be studied with an aim to improve therapeutic efficacy and survival. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12577233     DOI: 10.1053/sonc.2002.37375

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  2 in total

1.  Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.

Authors:  J Harder; B Riecken; O Kummer; C Lohrmann; F Otto; H Usadel; M Geissler; O Opitz; H Henss
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

2.  A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

Authors:  D C Doval; J S Sekhon; S K Gupta; J Fuloria; V K Shukla; S Gupta; B S Awasthy
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.